A new study followed patients with severe chronic pain for a year and found that opioids relieved pain and increased function no better than common drugs like acetaminophen and lidocaine. But the opioids carry the risk of more serious side effects, including addiction and death.
Una nueva investigación revela que estos crontroversiales medicamentos no son eficaces para tratar el dolor de largo plazo.
Although the potentially fatal disease is common among the incarcerated, treatment with the latest hepatitis drugs isn’t.
Medical debt is down across the country. In states that expanded Medicaid under the Affordable Care Act, the reduction is sharper.
The Affordable Care Act gave some Americans the chance to strike out on their own in new business ventures because they didn’t have to worry about keeping a job just for health insurance. But the repeal-and-replace efforts reignited this week create uncertainty about whether they can count on that insurance option in the future.
The U.S. government has been struggling to balance a surge in applicants for disability benefits with shrinking funds. An updated application process could make getting benefits even harder.
Ford Inbody has a degenerative disease and is carefully watching the GOP replacement health care bill. Though it covers preexisting conditions, it could still mean he’ll get less care for more money.
Once an elite swimmer and a Yale grad, Siphiwe Baleka now coaches 3,000 fellow truckers on the best ways to work out, eat right and stay connected on the road. Drivers say his wellness plan works.
Nick Fugate has a cognitive disability but held a job and was independent for years. Then he lost his dishwashing job and learned there are long delays getting help he needs from Medicaid in Kansas.
R.J. Reynolds has put $12 million into an effort to raise tobacco taxes in Missouri. But the proposed 60-cents per pack tax, still among the lowest in the nation, is not likely to make many smokers quit.
Apps and video chats are a part of many people’s days, so many industry leaders see big potential for medicine delivered remotely. But a lot of insurers still aren’t willing to pay for it.